US Neurodegenerative Disease Market Segment – Therapeutic Class Insights
The US Neurodegenerative Disease Market segment analysis categorizes therapies into disease-modifying drugs, symptomatic treatments, combination therapies, and supportive care. Disease-modifying treatments, including gene therapies and monoclonal antibodies, are increasingly adopted for their ability to slow disease progression. Symptomatic treatments continue to manage motor and cognitive...
0 Commentaires
0 Parts
83 Vue
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt